We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Double Yaaaaawn
MCB
If you do a bit of research on Affyxell it only as 1 employee the CEO . Who is on LinkedIn
But he won’t have a white coat on testing stem cells and updated the website.
Daewoong will be doing all the work my guess the website update was uploaded then Avacta or Daewoong have taken it down as it shows sensitive market information.
Yes I do.
MCB, you do realise that Daewoong is a Korean company.
Ophidian,
I was not doubting AffyXell as a credible Avacta product, just that a Korean website that goes down quickly and the home page in Korean all seems a bit unauthentic, but lets hope my cynicism is unfounded and we get some near term news!
I'm ever so slightly suspicious that a website for any size company in one of the most digitally engaged countries in the world would hit a data transfer limit, seems very strange to me. However there text on the site correlates with what we expect from them.
Whoa was panicing a little there, thought Al had bought a summer cottage in Korea.
Still got the juices running better than a pint mug of mocha coffee.
09.14 - noted; however, it still seems a valid pointer today. The breadth of Avacta initiatives is extraordinary imo. VGLA
that update is from a year ago - I just posted it for @MCB55
Ophidian
Interesting(?): ' whilst Avacta retains the rights to commercialise the Affimer proteins outside the field of cell therapies.' VGLA
01 Feb 2021
AffyXell $7.3 Million Series A Financing
Avacta’s next generation cell and gene therapy joint venture with Daewoong Pharmaceutical secures Series A venture funding
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that AffyXell Therapeutics (“AffyXell”), the joint venture with Daewoong Pharmaceutical (“Daewoong”), has closed a Series A venture capital investment of $7.3 million to further develop its pipeline of next generation cell and gene therapies.
AffyXell was established in January 2020 by Avacta and Daewoong as a Joint Venture to develop novel mesenchymal stem cell (MSC) therapies. AffyXell is combining Avacta’s Affimer platform with Daewoong’s MSC platform such that the stem cells are genetically modified to produce and secrete therapeutic Affimer proteins in situ in the patient. The Affimer proteins are designed to enhance the therapeutic effects of the MSC creating a novel, next generation cell therapy platform.
The Series A funding has been raised from a group of venture funds including Samsung Venture Investment Corporation, Shinhan Venture Investment, Smilegate Investment, Shinhan Investment Corporation, Kolon Investment, Stonebridge Ventures, and Gyeongnam Venture Investment.
The capital raised will be used by AffyXell to further the development of MSCs engineered to produce Affimer molecules generated by Avacta that suppress immune response and restore immune balance. While initially focusing on inflammatory and autoimmune diseases and prevention of organ transplant rejection, longer term goals could also include applications in regenerative medicine, infectious diseases and oncology.
Under the terms of the collaboration and licence agreement, Avacta’s research and development costs associated with the generation of the Affimer proteins are funded by AffyXell whilst Avacta retains the rights to commercialise the Affimer proteins outside the field of cell therapies.
Is this for real, coincindental (similar spelling from Chinese translation) or a Chinese copycat!?
Great find!
I noticed on Twitter you said the Series B for Affxell was/is opening; do you think/know if this is connected to Avacta’s investor roadshow, or are the two distinct?
Presumably Affyxell have made some progress to be able to open series B, so I just wonder if we might get a curveball update from Avacta as a consequence for the roadshow..?
Poirot
All Koreanon webpage but translated to this:
The excess data transfer amount is reset at 12 pm today and normal access is possible.
If you want to immediately unblock the site, choose one of the two methods below and apply
Normal connection is possible.
(1) Change the service to a higher specification than the current service
(2) Apply for additional data transfer option
What is data transfer volume?
When a site user visits the website, the data of the accessed page is transmitted to the user's PC.
At this time, the amount of data transferred to the user's PC is called the data transfer amount.
If you exceed the allowed data transfer amount of the service, the site you are using will be blocked
You’re right, that looks exciting!
Sorry I really have to dash.
Few brief points here though….
https://twitter.com/lee_williams97/status/1485884568213278721?s=21
Here’s some pics I got
https://twitter.com/lee_williams97/status/1485877600056659977?s=21
Will do summary shortly, hopefully site comes back online though.
Give us a clue, Poirot. What did you see?
Fancy giving us a summary?
I could access the whole site for a couple of hours this morning but struggling as well now.
Anyway it was some read whilst it lasted.
Excess date transfer!!!!! This is the translation!!!
Absolutely blown away with what Ive just read.
http://affyxell.com/
*website will need translating*